|
This initial report is submitted based on information related to an adverse event that was reported to fda through the medsun program (report no.(b)(4)) and communicated to the manufacturer by its u.S.Subsidiary.At the time of this report, the suspect device is not available for evaluation as it is in transit to the manufacturing site.Therefore, the root cause of the event has not been established.A follow-up report will be submitted if applicable.
|
|
According to the user facility report, a skin burn was observed during a thyroid radiofrequency ablation procedure on (b)(6) 2025.The affected area was treated with topical ointment and covered with a bandage.No additional medical or surgical treatment was reported.At the time of this report, the device has not yet been returned to the manufacturer for evaluation.
|
|
This follow-up report is submitted to provide the results of the manufacturer's completed evaluation of the returned device.As previously reported, a superficial skin burn was observed during a thyroid radiofrequency ablation procedure on (b)(6) 2025.The affected area was treated with topical ointment and covered with a bandage.No additional medical or surgical intervention was required.The suspect device was returned to the manufacturer and evaluated.Based on the completed inspection, testing, and analysis, no evidence of a device malfunction or performance abnormality was identified.
|
|
1.Device investigation this follow-up report is submitted by starmed co., ltd.Following the completion of a physical and functional investigation into the returned device (model: 18-07s10f, lot: de231113003).The manufacturer conducted a visual inspection, electrical performance testing, and cooling flow evaluation.The results indicated that the device was within the established design specifications, with no identified performance, functional, or aesthetic deviations.Additionally, a review of the device history record (dhr#: dhr-e-23111303) confirmed that the specific lot was manufactured and inspected in accordance with standardized quality processes without any reported non-conformances.2.Market data & complaint review to evaluate the occurrence of similar events, the manufacturer conducted a comprehensive search of the fda maude database and internal post-market surveillance (pms) records for the same product (star rf electrode fixed) covering the past five years (2021 to 2026 present).According to the search results, no identical or similar adverse events of skin burns have been identified globally under conditions where the device was functioning within its intended specifications.Notably, from 2021 to the present, approximately 7600 units of the same electrode model (star rf electrode fixed) have been distributed in the u.S.Market.Based on the information available at the time of this review, no pattern or trend of similar adverse events indicative of a device-related issue was identified 3.Clinical history of the facility and physician the reporting user facility, froedtert hospital milwaukee , has been utilizing starmed's rf ablation systems since 2021.Based on the information available to the manufacturer, the performing physician conducts approximately 2 - 5 procedures per month using starmed electrodes.Despite this frequency of clinical use, no prior adverse events had been reported by this physician and the hospital before this case, and no similar issues have occurred in the 4 - 6 procedures performed since this incident.No information suggesting a recurring device-related issue was identified from the facility's historical use of the product or from available post-event information.4.Conclusion based on the completed evaluation of the returned device and the review of available post-market information, no evidence of a device malfunction, manufacturing defect, or performance abnormality was identified that could directly account for the reported event.A definitive root cause for the reported superficial skin burn could not be established.
|